Apoptosis, fibrosis and senescence
1Division of Nephrology, Department of Internal Medicine, University of Virginia, Charlottesville, Va., USA.
Abstract:
Fibrosis is a major hallmark of progressive kidney disease. The cellular mechanisms that lead to kidney tissue fibrosis are complex and include, for example, increased inflammation, increased oxidative stress, and proximal tubule cell death in the form of apoptosis or senescence. Recent studies have identified TWEAK, a tumor necrosis factor-like weak inducer of apoptosis, as a novel cytokine that mediates kidney inflammation in models of renal fibrosis. Inhibition of apoptosis via TWEAK inhibition has been shown to reduce kidney fibrosis. Recent studies using lineage tracing suggest that interstitial pericytes/perivascular fibroblasts differentiate into myofibroblasts and undergo proliferative expansion during fibrosis. Furthermore, increased expression of nuclear peroxisome proliferator-activated receptor-α in proximal tubules can directly reduce increased expression of transforming growth factor-β1 and interstitial inflammation in models of renal fibrosis, which suggests preservation of proximal tubule cell metabolism and integrity represents an important new therapeutic target. In this review, the current evidence and potential molecular mechanisms involved in the development of kidney fibrosis are discussed.
Insights
Kidney fibrosis involves inflammation and cell death. Targeting tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and preserving proximal tubule cell integrity may offer new therapeutic strategies for kidney disease.
Area of Science:
- Nephrology
- Cellular Biology
- Molecular Medicine
Background:
- Kidney fibrosis is a key feature of progressive kidney disease.
- Mechanisms include inflammation, oxidative stress, and proximal tubule cell death (apoptosis/senescence).
Purpose of the Study:
- To review current evidence on kidney fibrosis development.
- To discuss potential molecular mechanisms and therapeutic targets.
Main Methods:
- Review of recent studies on renal fibrosis.
- Analysis of cellular mechanisms and cytokine involvement.
- Examination of lineage tracing and gene expression data.
Main Results:
- TWEAK (tumor necrosis factor-like weak inducer of apoptosis) mediates kidney inflammation and fibrosis.
- Inhibiting apoptosis via TWEAK blockade reduces kidney fibrosis.
- Pericytes/perivascular fibroblasts differentiate into myofibroblasts.
- Peroxisome proliferator-activated receptor-α activation reduces fibrosis markers.
Conclusions:
- TWEAK inhibition is a potential therapeutic strategy for kidney fibrosis.
- Preserving proximal tubule cell metabolism and integrity is a promising therapeutic target.
Related Concept Videos
Apoptosis
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Replicative Cell Senescence
Replicative Cell Senescence
Cellular Injury V: Apoptosis and Autophagy
Cellular Adaptation I: Introduction and Atrophy


